Glaucoma Drug Co. Hit With Class Action After Trial Tanks
By Jody Godoy ( April 30, 2015, 6:50 PM EDT) -- Glaucoma drug company Aerie Pharmaceuticals was slapped with a proposed class action Wednesday by investors who say the company misled them into believing its lead drug would perform better in clinical trials....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.